SCNI
Scinai Immunotherapeutics Ltd. - American Depositary Shares (SCNI)
$01
About Scinai Immunotherapeutics Ltd. - American Depositary Shares (SCNI)
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.
Details
Daily high
$2.15
Daily low
$1.98
Price at open
$1.98
52 Week High
$8.92
52 Week Low
$1.90
Market cap
1.7M
Dividend yield
0.00%
Volume
16,620
Avg. volume
23,693
P/E ratio
6.57
Scinai Immunotherapeutics Ltd. - American Depositary Shares News
Details
Daily high
$2.15
Daily low
$1.98
Price at open
$1.98
52 Week High
$8.92
52 Week Low
$1.90
Market cap
1.7M
Dividend yield
0.00%
Volume
16,620
Avg. volume
23,693
P/E ratio
6.57